Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Avicine: Completed Phase II trial enrollment

AVI BioPharma Inc. (AVII), Portland, Ore.
Product: Avicine
Business:

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE